Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia

NCT ID: NCT04298814

Last Updated: 2020-07-20

Basic Information

• Recruitment Status: WITHDRAWN
• Study Classification: OBSERVATIONAL
• Study Start Date: 2020-08-07
• Study Completion Date: 2020-12-30

Brief Summary

To analyze the intubation with severe covid-19 pneumonia, the infection rate of anesthesiologist after intubation, and summarizes the experience of how to avoid the infection of anesthesiologist and ensure the safety of patients with severe covid-19 pneumonia.

Detailed Description

To analyze the intubation time, intubation condition, intubation process, intubation times and success rate of patients with severe covid-19 pneumonia, the infection rate of anesthesiologist after intubation, the degree of respiratory improvement and survival rate of patients, and summarizes the experience of how to avoid the infection of anesthesiologist and ensure the safety of patients with severe covid-19 pneumonia.

Conditions

COVID-19; Endotracheal Intubation

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: PROSPECTIVE

Interventions

severe covid-19 pneumonia with ET

severe covid-19 pneumonia undergoing endotracheal intubation

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Wuhan residents;
• novel coronavirus pneumonia was found to be characterized by fever and cough. Laboratory tests revealed leukocyte or lymphocyte decrease, chest CT examination showed viral pneumonia changes, and was diagnosed as COVID-19 pneumonia according to the national health and Health Committee's new coronavirus pneumonia diagnosis and treatment plan (trial version fifth Revision).
• Severe and critical patients with covid-19 pneumonia in urgent need of tracheal intubation;
• Sign informed consent.

Exclusion Criteria

• Suspected patients with covid-19 pneumonia;
• Patients who need emergency endotracheal intubation due to other causes of respiratory failure;
• The family refused to sign the informed consent.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tongji Hospital

OTHER

Sponsor Role: lead

Responsible Party

aijun xu

associate professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Aijun XU, Dr.

Role: PRINCIPAL_INVESTIGATOR

Tongji Hospital

Locations

Tongji Hospital

Wuhan, Hubei, China

Countries

China

Other Identifiers

COVEI

Identifier Type: -

Identifier Source: org_study_id